Global Point Of Care
AFINION™ CRP Make Every Minute Count
When it comes to diagnosis and treatment, every moment matters. Diagnostic innovations such as C-reactive protein (CRP) point-of-care testing can help to inform decision making* – making the most of time for both the doctor and patient, as well as reducing unnecessary antibiotic prescribing.1-10 Afinion CRP is part of Abbott’s commitment to making every minute count in patient care.
Without change, amr is predicted to contribute to an estimated 10 million deaths a year by 2050.
Amr Threatens Our Ability To Protect Against Infectious Disease
Time is ticking in the battle against antimicrobial resistance (AMR). It’s a serious healthcare and economic problem. Overuse of antibiotics is a key driver of AMR and limits future effectiveness of treatments for tackling infection.1,11
Watch this video to learn how diagnostics innovations such as C-reactive protein (CRP) Point of Care Testing can help in the fight against Antimicrobial Resistance (AMR).
A Review Commissioned By The British Government Recommends The Following Strategies For Promoting Antimicrobial Stewardship:11
Keep antibiotics working
Make every consultation count
C-reactive protein (CRP) is a major acute phase biomarker, which can be used to differentiate between self-limiting or viral and severe bacterial infections, and helps HCPs to identify patients with RTIs who would benefit from antibiotics, and those who would not.1-10
In a number of studies, CRP POC testing has been found to:
Help resolve diagnostic uncertainty in patients with RTIs when used alongside clinical observation of signs and symptoms. 1,2,5,12
Reduce antibiotic prescribing for RTIs by as much as 23-42%3,5,6,13
Reduce antibiotic prescribing by GPs by more than 60% when combined with enhanced communication skills3,6
Antibiotics remain the most commonly prescribed drugs in nursing homes, with 47-79% of residents receiving at least one antibiotic course each year.19
Reduce diagnostic uncertainty in geriatric care14-18
Atypical presentation and fewer presenting signs and symptoms in older patients complicate diagnosis and delay initiation of adequate treatment.15
However, several studies have confirmed the usefulness of CRP testing in geriatric patients.15-18
Download the Afinion CRP brochure to learn how CRP testing at the point of care can transform your consultations and help to guide antibiotic prescribing in adult and geriatric patients.
ALL-IN-ONE
The Afinion CRP cartridge has been made with an all-in-one, user-friendly design – and with no pre-analytical handling required, achieving accurate results is even simpler.
#KEEPANTIBIOTICSWORKING
At Abbott, we are committed to #makeeveryminutecount and we can serve you and our common mission to reduce AMR and #keepantibioticsworking with Afinion CRP. To find out more about Abbott, follow us on social media:
Featured in this Story:
AFINION™ CRP
Afinion CRP is a rapid, in vitro diagnostic test that helps reduce diagnostic uncertainty and guide antibiotic decision-making at the point of care.
